Anti-WBSCR17 Antibody

WBSCR17 (Williams-Beuren syndrome critical region 17) encodes a polypeptide N-acetylgalactosaminyltransferase (GalNAc-T17) that initiates mucin-type O-glycosylation in the Golgi apparatus. This rabbit polyclonal reagent from Antibodies.com is raised against the human WBSCR17 sequence and is validated for Western Blot detection of the endogenous protein in both human and mouse samples.

The unconjugated IgG is supplied as 100 µL of ready-to-use antiserum in a single vial, suitable for downstream chemiluminescent or fluorescent secondary detection workflows. Store aliquots at -20 °C in a frost-free freezer and avoid repeated freeze-thaw cycles to preserve activity. The polyclonal format ensures recognition of multiple epitopes on the glycosyltransferase, which is useful when examining expression patterns of GalNAc-T family members across tissues.

Researchers investigating O-glycosylation pathways, congenital disorders linked to the Williams-Beuren region, or Golgi-resident enzyme trafficking will find this antibody a reliable tool for confirming target expression in cell culture lysates and tissue homogenates.